CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)Business Wire • 05/04/23
Gilead Posts Bullish Cancer Drug Sales, But Profit Questions LingerInvestors Business Daily • 04/27/23
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/20/23
Get Income On Gilead Stock, Or Buy It At A Discount With This Option TradeInvestors Business Daily • 04/20/23
Veklury® (Remdesivir) Efficacy and Safety Profile Further Demonstrated in Vulnerable Patient PopulationsBusiness Wire • 04/16/23
Gilead Sciences to Release First Quarter 2023 Financial Results on Thursday, April 27, 2023Business Wire • 04/13/23
Why 7 of the Highest-Yielding ‘Strong Buy' Health Care Stocks Are the Absolute Best 2023 Buys24/7 Wall Street • 04/12/23